---
figid: PMC2797270__zbc0500995250008
figtitle: Summary of Trif-biased signaling and selective p38 activation by sMLA
organisms:
- Mus musculus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC2797270
filename: zbc0500995250008.jpg
figlink: /pmc/articles/PMC2797270/figure/F8/
number: F8
caption: Summary of Trif-biased signaling and selective p38 activation by sMLA. Upon
  activating the TLR4 complex, sMLA only weakly induces downstream events known to
  be activated through the TRIF/TRAF6/TAK1 axis, such as activation of IKKα/β and
  JNK. These kinases are activated strongly by sDLA, which leads to increased activation
  of transcription factors required to activate COX-2 and MCP-1. In contrast, sMLA
  treatment results in equivalent IRF3 activation downstream of TLR4/TRIF and p38
  activation as compared with sDLA; this signaling results in potent activation of
  not only TRIF-associated IP-10 but also proinflammatory TNFα and anti-inflammatory
  IL-10.
papertitle: Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl
  Lipid A.
reftext: Caglar Cekic, et al. J Biol Chem. 2009 Nov 13;284(46):31982-31991.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9510288
figid_alias: PMC2797270__F8
figtype: Figure
redirect_from: /figures/PMC2797270__F8
ndex: a6e2e6d9-dee0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2797270__zbc0500995250008.html
  '@type': Dataset
  description: Summary of Trif-biased signaling and selective p38 activation by sMLA.
    Upon activating the TLR4 complex, sMLA only weakly induces downstream events known
    to be activated through the TRIF/TRAF6/TAK1 axis, such as activation of IKKα/β
    and JNK. These kinases are activated strongly by sDLA, which leads to increased
    activation of transcription factors required to activate COX-2 and MCP-1. In contrast,
    sMLA treatment results in equivalent IRF3 activation downstream of TLR4/TRIF and
    p38 activation as compared with sDLA; this signaling results in potent activation
    of not only TRIF-associated IP-10 but also proinflammatory TNFα and anti-inflammatory
    IL-10.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LBP
  - EHHADH
  - RPSA
  - CD14
  - NDUFA2
  - LY96
  - MAL
  - MRTFA
  - TIRAP
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - MAP3K7
  - NR2C2
  - TBK1
  - ANOS1
  - SERPINA4
  - GRIK4
  - TUBA1B
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - NFKB1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - IRF3
  - MYD88
  - TLR4
  - Lbp
  - Ehhadh
  - Cd14
  - Ly96
  - Mal
  - Tirap
  - Mrtfa
  - Tmed7
  - Ticam2
  - Nr2c2
  - Map3k7
  - Tbk1
  - Klk1b9
  - Klk1
  - Tcf3
  - Grik4
  - Mapk8
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Nfkb1
  - Jun
  - Irf3
  - Myd88
  - Tlr4
  - Mtpalpha
  - mal
  - bs
  - Mrtf
  - TRAM
  - Tak1
  - bsk
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Dif
  - dl
  - Rel
  - AP-1gamma
  - Jra
  - kay
  - Toll-4
  - tirap
  - malb
  - tram1
  - tbk1
  - mapk8b
  - mapk14a
  - irf3
  - myd88
---
